Synopsis
Synopsis
0
VMF
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Molecular Weight | 136.11 g/mol |
---|---|
Molecular Formula | C5H4N4O |
XLogP3 | -0.5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 0 |
Exact Mass | 136.03851076 g/mol |
Monoisotopic Mass | 136.03851076 g/mol |
Topological Polar Surface Area | 65.8 A^2 |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 275 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 10 | |
---|---|
Drug Name | Allopurinol |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | Allopurinol is known chemically as 1,5-Dihydro-4H-pyrazolo[3,4-d ]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Its solubility in water at 37C is 80 mg/dL and is greater in an alkaline solution. Allopurinol Table... |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Watson Labs; Vintage Pharms; Ipca Labs; Mutual Pharm; Apotex; Accord Hlthcare; Sun Pharm Inds; Northstar Hlthcare; Mylan |
2 of 10 | |
---|---|
Drug Name | Allopurinol sodium |
PubMed Health | Allopurinol (Injection) |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ALOPRIM (allopurinol sodium) for Injection is the brand name for allopurinol, a xanthine oxidase inhibitor. ALOPRIM (allopurinol sodium) for Injection is a sterile solution for intravenous infusion only. It is available in vials as the sterile lyophi... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
3 of 10 | |
---|---|
Drug Name | Aloprim |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ZYLOPRIM (allopurinol) has the following structural formula:ZYLOPRIM is known chemically as 1,5-dihydro-4H-pyrazolo [3,4-d]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Each scored white tablet contains 100 mg allo... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Mylan Institutional |
4 of 10 | |
---|---|
Drug Name | Lopurin |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Dr Reddys La |
5 of 10 | |
---|---|
Drug Name | Zyloprim |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Prometheus Labs |
6 of 10 | |
---|---|
Drug Name | Allopurinol |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | Allopurinol is known chemically as 1,5-Dihydro-4H-pyrazolo[3,4-d ]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Its solubility in water at 37C is 80 mg/dL and is greater in an alkaline solution. Allopurinol Table... |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Watson Labs; Vintage Pharms; Ipca Labs; Mutual Pharm; Apotex; Accord Hlthcare; Sun Pharm Inds; Northstar Hlthcare; Mylan |
7 of 10 | |
---|---|
Drug Name | Allopurinol sodium |
PubMed Health | Allopurinol (Injection) |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ALOPRIM (allopurinol sodium) for Injection is the brand name for allopurinol, a xanthine oxidase inhibitor. ALOPRIM (allopurinol sodium) for Injection is a sterile solution for intravenous infusion only. It is available in vials as the sterile lyophi... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Eurohlth Intl |
8 of 10 | |
---|---|
Drug Name | Aloprim |
PubMed Health | Allopurinol |
Drug Classes | Antigout, Urinary Stone Agent |
Drug Label | ZYLOPRIM (allopurinol) has the following structural formula:ZYLOPRIM is known chemically as 1,5-dihydro-4H-pyrazolo [3,4-d]pyrimidin-4-one. It is a xanthine oxidase inhibitor which is administered orally. Each scored white tablet contains 100 mg allo... |
Active Ingredient | Allopurinol sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 500mg base/vial |
Market Status | Prescription |
Company | Mylan Institutional |
9 of 10 | |
---|---|
Drug Name | Lopurin |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Dr Reddys La |
10 of 10 | |
---|---|
Drug Name | Zyloprim |
Active Ingredient | Allopurinol |
Dosage Form | Tablet |
Route | Oral |
Strength | 300mg; 100mg |
Market Status | Prescription |
Company | Prometheus Labs |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37104
Submission : 2023-01-20
Status : Active
Type : II
Certificate Number : CEP 2023-029 - Rev 00
Issue Date : 2024-06-10
Type : Chemical
Substance Number : 576
Status : Valid
NDC Package Code : 49716-328
Start Marketing Date : 2023-10-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39568
Submission : 2024-03-05
Status : Active
Type : II
NDC Package Code : 61281-9750
Start Marketing Date : 2023-07-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
JPN Pharma offers excellence in API manufacturing through precision, innovation & quality, delivering solutions to the pharma industry
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Certificate Number : R1-CEP 1996-032 - Rev 05
Issue Date : 2019-08-09
Type : Chemical
Substance Number : 576
Status : Valid
Registration Number : 231MF10077
Registrant's Address : H-1106 BUDAPEST KERESZTURI UT 30-38 HUNGARY
Initial Date of Registration : 2019-03-29
Latest Date of Registration :
Registrant Name : Masung LS Co., Ltd.
Registration Date : 2021-01-25
Registration Number : 20210125-209-J-511
Manufacturer Name : EGIS Pharmaceuticals Plc.
Manufacturer Address : Kereszturi ut 30-38., Budapest, 1106, Hungary
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Octavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
61
PharmaCompass offers a list of Allopurinol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Allopurinol manufacturer or Allopurinol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Allopurinol manufacturer or Allopurinol supplier.
PharmaCompass also assists you with knowing the Allopurinol API Price utilized in the formulation of products. Allopurinol API Price is not always fixed or binding as the Allopurinol Price is obtained through a variety of data sources. The Allopurinol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Milurit manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milurit, including repackagers and relabelers. The FDA regulates Milurit manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milurit API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Milurit manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Milurit supplier is an individual or a company that provides Milurit active pharmaceutical ingredient (API) or Milurit finished formulations upon request. The Milurit suppliers may include Milurit API manufacturers, exporters, distributors and traders.
click here to find a list of Milurit suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Milurit DMF (Drug Master File) is a document detailing the whole manufacturing process of Milurit active pharmaceutical ingredient (API) in detail. Different forms of Milurit DMFs exist exist since differing nations have different regulations, such as Milurit USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Milurit DMF submitted to regulatory agencies in the US is known as a USDMF. Milurit USDMF includes data on Milurit's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Milurit USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Milurit suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Milurit Drug Master File in Japan (Milurit JDMF) empowers Milurit API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Milurit JDMF during the approval evaluation for pharmaceutical products. At the time of Milurit JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Milurit suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Milurit Drug Master File in Korea (Milurit KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Milurit. The MFDS reviews the Milurit KDMF as part of the drug registration process and uses the information provided in the Milurit KDMF to evaluate the safety and efficacy of the drug.
After submitting a Milurit KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Milurit API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Milurit suppliers with KDMF on PharmaCompass.
A Milurit CEP of the European Pharmacopoeia monograph is often referred to as a Milurit Certificate of Suitability (COS). The purpose of a Milurit CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Milurit EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Milurit to their clients by showing that a Milurit CEP has been issued for it. The manufacturer submits a Milurit CEP (COS) as part of the market authorization procedure, and it takes on the role of a Milurit CEP holder for the record. Additionally, the data presented in the Milurit CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Milurit DMF.
A Milurit CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Milurit CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Milurit suppliers with CEP (COS) on PharmaCompass.
A Milurit written confirmation (Milurit WC) is an official document issued by a regulatory agency to a Milurit manufacturer, verifying that the manufacturing facility of a Milurit active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Milurit APIs or Milurit finished pharmaceutical products to another nation, regulatory agencies frequently require a Milurit WC (written confirmation) as part of the regulatory process.
click here to find a list of Milurit suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Milurit as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Milurit API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Milurit as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Milurit and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Milurit NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Milurit suppliers with NDC on PharmaCompass.
Milurit Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Milurit GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Milurit GMP manufacturer or Milurit GMP API supplier for your needs.
A Milurit CoA (Certificate of Analysis) is a formal document that attests to Milurit's compliance with Milurit specifications and serves as a tool for batch-level quality control.
Milurit CoA mostly includes findings from lab analyses of a specific batch. For each Milurit CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Milurit may be tested according to a variety of international standards, such as European Pharmacopoeia (Milurit EP), Milurit JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milurit USP).